@2024 - All Right Reserved.
Medicare Part D prescription drug plans and Medicare Advantage plans cover various diabetes-related costs, including Trulicity. However, out-of-pocket costs may apply. Trulicity is a once-weekly ...
Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to ...
Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company's older diabetes treatment, Trulicity.
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C and weight In the trial, Mounjaro was associated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback